Immune biomarkers in the spectrum of childhood noncommunicable diseases  Chrysanthi Skevaki, MD, PhD, Jolice Van den Berg, PhD, Nicholas Jones, BSc, Johan Garssen, MD, PhD, Peter Vuillermin, MD, PhD, Michael Levin, MD, PhD, Alan Landay, PhD, Harald Renz, MD, Philip C. Calder, PhD, Catherine A. Thornton, PhD  Journal of Allergy and Clinical Immunology  Volume 137, Issue 5, Pages 1302-1316 (May 2016) DOI: 10.1016/j.jaci.2016.03.012 Copyright © 2016 Terms and Conditions

Fig 1 Pipeline from biomarker discovery to clinical implementation. Journal of Allergy and Clinical Immunology 2016 137, 1302-1316DOI: (10.1016/j.jaci.2016.03.012) Copyright © 2016 Terms and Conditions

Fig 2 Factors that potentially modify measurable factors within human biological samples: many of these factors also modify the risk and phenotype of NCDs. Journal of Allergy and Clinical Immunology 2016 137, 1302-1316DOI: (10.1016/j.jaci.2016.03.012) Copyright © 2016 Terms and Conditions